Atherosclerosis is a chronic inflammatory disease, in which the immune system has a
prominent role in its development and progression. Inflammation-induced endothelial …

Endothelial dysfunction is one of the earliest manifestations of atherosclerosis, contributing
to its development and progression. Mental stress induces endothelial dysfunction through …

Chronic subclinical inflammation is a key process in the pathogenesis of atherosclerotic
cardiovascular disease (ASCVD). Along with lipids, inflammation is essential for the initiation …

Objective To synthesize more conclusive evidence on the anti-inflammatory effects of
angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers …

SARS-CoV-2—severe acute respiratory syndrome coronavirus 2; MetS—metabolic
syndrome; DMT2—diabetes mellitus type 2; MAFLD—metabolic-associated fatty liver …

Background Coronary heart disease (CHD) is characterized by forming of arterial plaques
composed mainly of lipids, calcium, and inflammatory cells. These plaques narrow the …

Chronic systemic inflammation is a risk factor for cardiovascular (CV) disease (CVD).
Whether this relationship extends to subclinical inflammation, quantified by values of …

Background Several trials have considered the safety and clinical benefits of colchicine as a
treatment option for secondary prevention in patients with coronary atherosclerotic heart …

Colchicine is an effective anti-inflammatory agent used to treat gout, coronary artery disease,
viral pericarditis, and familial Mediterranean fever. It has been found to act by preventing the …

Colchicine has demonstrated promising effects in inhibiting local and systemic inflammation
during acute coronary syndrome (ACS). However, the efficacy of colchicine in ACS is …